Polypharmacological Potential of Phosphodiesterase 5 Inhibitors for the Treatment of Neurocognitive Disorders. [PDF]
Kumar A, Kim F, Song DK, Choung JJ.
europepmc +1 more source
Increased bleeding risk with phosphodiesterase-5 inhibitors after left ventricular assist device implantation. [PDF]
Jakstaite AM +9 more
europepmc +1 more source
Molecular Dynamics-Assisted Discovery of Novel Phosphodiesterase-5 Inhibitors Targeting a Unique Allosteric Pocket. [PDF]
Luo W, Liu R, Cai X, Zhou Q, Zhang C.
europepmc +1 more source
A Brief Overview of Cholinergic and Phosphodiesterase-5 Inhibitors in Diabetic Bladder Dysfunction. [PDF]
Kallinikas G +15 more
europepmc +1 more source
Effect of Phosphodiesterase-5 Inhibitors on the Treatment of Male Infertility: A Systematic Review and Meta-Analysis. [PDF]
Dong L +5 more
europepmc +1 more source
Phosphodiesterase type 5 inhibitors after left ventricular assist device: no free lunch?
E. Wilson Grandin, Jeffrey J. Teuteberg
doaj +1 more source
Compound Xuanju capsules combined with phosphodiesterase-5 inhibitors as a new strategy for erectile dysfunction: a meta-analysis and trial sequential analysis. [PDF]
Li R +6 more
europepmc +1 more source
Exploring Providers' Behaviors, Attitudes, and Preferences on the Treatment of Pulmonary Arterial Hypertension With Endothelin Receptor Antagonist (ERA) + Phosphodiesterase-5 Inhibitors (PDE5i). [PDF]
Kolaitis NA +10 more
europepmc +1 more source
Phosphodiesterase-5 inhibitors for colon cancer chemoprevention
Islam, Bianca N., Browning, Darren D.
openaire +2 more sources
Covid-19-induced pulmonary hypertension in children, and the use of phosphodiesterase-5 inhibitors. [PDF]
Dimiati H, Umara DA, Naufal I.
europepmc +1 more source

